Question explored with the scientific record
Conversation so far
- 1 Muscle tension dysphonia + a private exchange
- 2 What other treatments besides voice exercises help MTD?
Answered on this page ↓
What other treatments besides voice exercises help MTD?
Botulinum toxin is the one non-voice treatment with real trial evidence, but it's for a different diagnosis (spasmodic dysphonia), not MTD.
The records that matter here are about botulinum toxin injections into the vocal muscles. A Cochrane review found it effective for spasmodic dysphonia based on randomized trials [2], and a broader review rated the evidence for spasmodic dysphonia as the strongest of any head and neck condition, level 1a [5]. In one series of 31 patients, about two-thirds got substantial voice improvement, lasting 2 to 28 months [1]. But that was adductor laryngeal dystonia, a neurological disorder, not muscle tension dysphonia. Injecting a patient whose problem is overuse, not dystonia, is a different bet.
The side effects are real. In that series, 17 of the responders got a breathy voice for 1 to 14 days, and 7 had mild trouble swallowing in the first week [1]. Botox weakens the muscle; it doesn't retrain it.
| Treatment | Evidence level | Population studied |
|---|---|---|
| Botulinum toxin | Randomized trials (1a) [2][5] | Spasmodic dysphonia, not MTD |
| Botulinum toxin | Case series, ~2 in 3 improved [1] | Adductor dystonia |
| Injection augmentation | No advantage over Botox [4] | Essential voice tremor |
Nothing in this evidence tests botulinum toxin in MTD specifically. The tremor and granuloma studies are other diagnoses entirely [3][4]. So the honest answer is that Botox is a plausible option only if the diagnosis is actually dystonia, and the evidence for it in true MTD is not here.
My call: get the diagnosis confirmed before considering injections, because the trial evidence supports Botox for spasmodic dysphonia, not MTD. Confidence: moderate on that distinction, low on Botox for MTD itself.
Sources used 5
-
Botulinum toxin treatment for spasmodic dysphonia (adductor laryngeal dystonia) Experience with 31 patients
Botulinum toxin injections into the vocalis muscles yielded substantial voice improvement in about two-thirds of patients with adductor laryngeal dystonia, with effects lasting 2–28 months and common transient breathy voice and mild dysphagia.
DOI: meta/10.3109/14015439409102354 -
Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review
This systematic Cochrane review evaluates the efficacy of botulinum toxin therapy for treating spasmodic dysphonia, highlighting its effectiveness based on randomized controlled trials.
DOI: 10.1191/0269215506cr931oa -
Botulinum Toxin A for Treatment of Contact Granuloma
This study presents a retrospective case series of 22 patients treated with botulinum toxin A injections for contact granuloma, demonstrating a 77% cure rate, particularly effective for grades 1, 2, and 3 granulomas.
DOI: 10.1016/j.jvoice.2015.07.015 -
A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor
In seven adults with essential voice tremor, this prospective crossover trial compared botulinum toxin chemodenervation (BTX) with injection augmentation (IA) and found no clear advantage of IA over BTX across multidimensional voice assessments, though both treatments yielded mi…
DOI: 10.1002/lary.26911 -
An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions
An evidence-based review summarizing the efficacy and safety of botulinum toxin (Botox) across non-cosmetic head and neck conditions, finding strong evidence for certain movement disorders (e.g., spasmodic dysphonia, cervical dystonia) and mixed/no evidence for others, while hig…
DOI: 10.1177/2042533312472115